Global RNA-Based Therapeutics and Vaccines Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the RNA-Based Therapeutics and Vaccines market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global RNA-Based Therapeutics and Vaccines market are covered in Chapter 9:
Santaris Pharma A/S (A Roche Company)
Regulus Therapeutics, Inc.
Dicerna Pharmaceuticals, Inc.
Arbutus Biopharma Corp.
CureVac AG
Alnylam Pharmaceuticals, Inc.
BioNTech AG
miRagen Therapeutics
Quark Pharmaceuticals, Inc.
Moderna Therapeutics, Inc.
Marina Biotech, Inc.
Arrowhead Pharmaceuticals, Inc.
In Chapter 5 and Chapter 7.3, based on types, the RNA-Based Therapeutics and Vaccines market from 2017 to 2027 is primarily split into:
RNA-based Therapeutics
RNA-Based Vaccines
In Chapter 6 and Chapter 7.4, based on applications, the RNA-Based Therapeutics and Vaccines market from 2017 to 2027 covers:
Oncology
Immunology
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Genetic Diseases
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the RNA-Based Therapeutics and Vaccines market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the RNA-Based Therapeutics and Vaccines Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global RNA-Based Therapeutics and Vaccines market are covered in Chapter 9:
Santaris Pharma A/S (A Roche Company)
Regulus Therapeutics, Inc.
Dicerna Pharmaceuticals, Inc.
Arbutus Biopharma Corp.
CureVac AG
Alnylam Pharmaceuticals, Inc.
BioNTech AG
miRagen Therapeutics
Quark Pharmaceuticals, Inc.
Moderna Therapeutics, Inc.
Marina Biotech, Inc.
Arrowhead Pharmaceuticals, Inc.
In Chapter 5 and Chapter 7.3, based on types, the RNA-Based Therapeutics and Vaccines market from 2017 to 2027 is primarily split into:
RNA-based Therapeutics
RNA-Based Vaccines
In Chapter 6 and Chapter 7.4, based on applications, the RNA-Based Therapeutics and Vaccines market from 2017 to 2027 covers:
Oncology
Immunology
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Genetic Diseases
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the RNA-Based Therapeutics and Vaccines market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the RNA-Based Therapeutics and Vaccines Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 RNA-BASED THERAPEUTICS AND VACCINES MARKET OVERVIEW
1.1 Product Overview and Scope of RNA-Based Therapeutics and Vaccines Market
1.2 RNA-Based Therapeutics and Vaccines Market Segment by Type
1.2.1 Global RNA-Based Therapeutics and Vaccines Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global RNA-Based Therapeutics and Vaccines Market Segment by Application
1.3.1 RNA-Based Therapeutics and Vaccines Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global RNA-Based Therapeutics and Vaccines Market, Region Wise (2017-2027)
1.4.1 Global RNA-Based Therapeutics and Vaccines Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States RNA-Based Therapeutics and Vaccines Market Status and Prospect (2017-2027)
1.4.3 Europe RNA-Based Therapeutics and Vaccines Market Status and Prospect (2017-2027)
1.4.4 China RNA-Based Therapeutics and Vaccines Market Status and Prospect (2017-2027)
1.4.5 Japan RNA-Based Therapeutics and Vaccines Market Status and Prospect (2017-2027)
1.4.6 India RNA-Based Therapeutics and Vaccines Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia RNA-Based Therapeutics and Vaccines Market Status and Prospect (2017-2027)
1.4.8 Latin America RNA-Based Therapeutics and Vaccines Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa RNA-Based Therapeutics and Vaccines Market Status and Prospect (2017-2027)
1.5 Global Market Size of RNA-Based Therapeutics and Vaccines (2017-2027)
1.5.1 Global RNA-Based Therapeutics and Vaccines Market Revenue Status and Outlook (2017-2027)
1.5.2 Global RNA-Based Therapeutics and Vaccines Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the RNA-Based Therapeutics and Vaccines Market
2 INDUSTRY OUTLOOK
2.1 RNA-Based Therapeutics and Vaccines Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 RNA-Based Therapeutics and Vaccines Market Drivers Analysis
2.4 RNA-Based Therapeutics and Vaccines Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 RNA-Based Therapeutics and Vaccines Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on RNA-Based Therapeutics and Vaccines Industry Development
3 GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET LANDSCAPE BY PLAYER
3.1 Global RNA-Based Therapeutics and Vaccines Sales Volume and Share by Player (2017-2022)
3.2 Global RNA-Based Therapeutics and Vaccines Revenue and Market Share by Player (2017-2022)
3.3 Global RNA-Based Therapeutics and Vaccines Average Price by Player (2017-2022)
3.4 Global RNA-Based Therapeutics and Vaccines Gross Margin by Player (2017-2022)
3.5 RNA-Based Therapeutics and Vaccines Market Competitive Situation and Trends
3.5.1 RNA-Based Therapeutics and Vaccines Market Concentration Rate
3.5.2 RNA-Based Therapeutics and Vaccines Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL RNA-BASED THERAPEUTICS AND VACCINES SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global RNA-Based Therapeutics and Vaccines Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global RNA-Based Therapeutics and Vaccines Revenue and Market Share, Region Wise (2017-2022)
4.3 Global RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States RNA-Based Therapeutics and Vaccines Market Under COVID-19
4.5 Europe RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe RNA-Based Therapeutics and Vaccines Market Under COVID-19
4.6 China RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China RNA-Based Therapeutics and Vaccines Market Under COVID-19
4.7 Japan RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan RNA-Based Therapeutics and Vaccines Market Under COVID-19
4.8 India RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India RNA-Based Therapeutics and Vaccines Market Under COVID-19
4.9 Southeast Asia RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia RNA-Based Therapeutics and Vaccines Market Under COVID-19
4.10 Latin America RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America RNA-Based Therapeutics and Vaccines Market Under COVID-19
4.11 Middle East and Africa RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa RNA-Based Therapeutics and Vaccines Market Under COVID-19
5 GLOBAL RNA-BASED THERAPEUTICS AND VACCINES SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global RNA-Based Therapeutics and Vaccines Sales Volume and Market Share by Type (2017-2022)
5.2 Global RNA-Based Therapeutics and Vaccines Revenue and Market Share by Type (2017-2022)
5.3 Global RNA-Based Therapeutics and Vaccines Price by Type (2017-2022)
5.4 Global RNA-Based Therapeutics and Vaccines Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global RNA-Based Therapeutics and Vaccines Sales Volume, Revenue and Growth Rate of RNA-based Therapeutics (2017-2022)
5.4.2 Global RNA-Based Therapeutics and Vaccines Sales Volume, Revenue and Growth Rate of RNA-Based Vaccines (2017-2022)
6 GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET ANALYSIS BY APPLICATION
6.1 Global RNA-Based Therapeutics and Vaccines Consumption and Market Share by Application (2017-2022)
6.2 Global RNA-Based Therapeutics and Vaccines Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Oncology (2017-2022)
6.3.2 Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Immunology (2017-2022)
6.3.3 Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Ophthalmology (2017-2022)
6.3.4 Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Cardiovascular Diseases (2017-2022)
6.3.5 Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Infectious Diseases (2017-2022)
6.3.6 Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Genetic Diseases (2017-2022)
6.3.7 Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET FORECAST (2022-2027)
7.1 Global RNA-Based Therapeutics and Vaccines Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global RNA-Based Therapeutics and Vaccines Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global RNA-Based Therapeutics and Vaccines Price and Trend Forecast (2022-2027)
7.2 Global RNA-Based Therapeutics and Vaccines Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States RNA-Based Therapeutics and Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe RNA-Based Therapeutics and Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China RNA-Based Therapeutics and Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan RNA-Based Therapeutics and Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India RNA-Based Therapeutics and Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia RNA-Based Therapeutics and Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America RNA-Based Therapeutics and Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa RNA-Based Therapeutics and Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.3 Global RNA-Based Therapeutics and Vaccines Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global RNA-Based Therapeutics and Vaccines Revenue and Growth Rate of RNA-based Therapeutics (2022-2027)
7.3.2 Global RNA-Based Therapeutics and Vaccines Revenue and Growth Rate of RNA-Based Vaccines (2022-2027)
7.4 Global RNA-Based Therapeutics and Vaccines Consumption Forecast by Application (2022-2027)
7.4.1 Global RNA-Based Therapeutics and Vaccines Consumption Value and Growth Rate of Oncology(2022-2027)
7.4.2 Global RNA-Based Therapeutics and Vaccines Consumption Value and Growth Rate of Immunology(2022-2027)
7.4.3 Global RNA-Based Therapeutics and Vaccines Consumption Value and Growth Rate of Ophthalmology(2022-2027)
7.4.4 Global RNA-Based Therapeutics and Vaccines Consumption Value and Growth Rate of Cardiovascular Diseases(2022-2027)
7.4.5 Global RNA-Based Therapeutics and Vaccines Consumption Value and Growth Rate of Infectious Diseases(2022-2027)
7.4.6 Global RNA-Based Therapeutics and Vaccines Consumption Value and Growth Rate of Genetic Diseases(2022-2027)
7.4.7 Global RNA-Based Therapeutics and Vaccines Consumption Value and Growth Rate of Others(2022-2027)
7.5 RNA-Based Therapeutics and Vaccines Market Forecast Under COVID-19
8 RNA-BASED THERAPEUTICS AND VACCINES MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 RNA-Based Therapeutics and Vaccines Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of RNA-Based Therapeutics and Vaccines Analysis
8.6 Major Downstream Buyers of RNA-Based Therapeutics and Vaccines Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the RNA-Based Therapeutics and Vaccines Industry
9 PLAYERS PROFILES
9.1 Santaris Pharma A/S (A Roche Company)
9.1.1 Santaris Pharma A/S (A Roche Company) Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
9.1.3 Santaris Pharma A/S (A Roche Company) Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Regulus Therapeutics, Inc.
9.2.1 Regulus Therapeutics, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
9.2.3 Regulus Therapeutics, Inc. Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Dicerna Pharmaceuticals, Inc.
9.3.1 Dicerna Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
9.3.3 Dicerna Pharmaceuticals, Inc. Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Arbutus Biopharma Corp.
9.4.1 Arbutus Biopharma Corp. Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
9.4.3 Arbutus Biopharma Corp. Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 CureVac AG
9.5.1 CureVac AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
9.5.3 CureVac AG Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Alnylam Pharmaceuticals, Inc.
9.6.1 Alnylam Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
9.6.3 Alnylam Pharmaceuticals, Inc. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 BioNTech AG
9.7.1 BioNTech AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
9.7.3 BioNTech AG Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 miRagen Therapeutics
9.8.1 miRagen Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
9.8.3 miRagen Therapeutics Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Quark Pharmaceuticals, Inc.
9.9.1 Quark Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
9.9.3 Quark Pharmaceuticals, Inc. Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Moderna Therapeutics, Inc.
9.10.1 Moderna Therapeutics, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
9.10.3 Moderna Therapeutics, Inc. Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Marina Biotech, Inc.
9.11.1 Marina Biotech, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
9.11.3 Marina Biotech, Inc. Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Arrowhead Pharmaceuticals, Inc.
9.12.1 Arrowhead Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
9.12.3 Arrowhead Pharmaceuticals, Inc. Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of RNA-Based Therapeutics and Vaccines Market
1.2 RNA-Based Therapeutics and Vaccines Market Segment by Type
1.2.1 Global RNA-Based Therapeutics and Vaccines Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global RNA-Based Therapeutics and Vaccines Market Segment by Application
1.3.1 RNA-Based Therapeutics and Vaccines Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global RNA-Based Therapeutics and Vaccines Market, Region Wise (2017-2027)
1.4.1 Global RNA-Based Therapeutics and Vaccines Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States RNA-Based Therapeutics and Vaccines Market Status and Prospect (2017-2027)
1.4.3 Europe RNA-Based Therapeutics and Vaccines Market Status and Prospect (2017-2027)
1.4.4 China RNA-Based Therapeutics and Vaccines Market Status and Prospect (2017-2027)
1.4.5 Japan RNA-Based Therapeutics and Vaccines Market Status and Prospect (2017-2027)
1.4.6 India RNA-Based Therapeutics and Vaccines Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia RNA-Based Therapeutics and Vaccines Market Status and Prospect (2017-2027)
1.4.8 Latin America RNA-Based Therapeutics and Vaccines Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa RNA-Based Therapeutics and Vaccines Market Status and Prospect (2017-2027)
1.5 Global Market Size of RNA-Based Therapeutics and Vaccines (2017-2027)
1.5.1 Global RNA-Based Therapeutics and Vaccines Market Revenue Status and Outlook (2017-2027)
1.5.2 Global RNA-Based Therapeutics and Vaccines Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the RNA-Based Therapeutics and Vaccines Market
2 INDUSTRY OUTLOOK
2.1 RNA-Based Therapeutics and Vaccines Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 RNA-Based Therapeutics and Vaccines Market Drivers Analysis
2.4 RNA-Based Therapeutics and Vaccines Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 RNA-Based Therapeutics and Vaccines Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on RNA-Based Therapeutics and Vaccines Industry Development
3 GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET LANDSCAPE BY PLAYER
3.1 Global RNA-Based Therapeutics and Vaccines Sales Volume and Share by Player (2017-2022)
3.2 Global RNA-Based Therapeutics and Vaccines Revenue and Market Share by Player (2017-2022)
3.3 Global RNA-Based Therapeutics and Vaccines Average Price by Player (2017-2022)
3.4 Global RNA-Based Therapeutics and Vaccines Gross Margin by Player (2017-2022)
3.5 RNA-Based Therapeutics and Vaccines Market Competitive Situation and Trends
3.5.1 RNA-Based Therapeutics and Vaccines Market Concentration Rate
3.5.2 RNA-Based Therapeutics and Vaccines Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL RNA-BASED THERAPEUTICS AND VACCINES SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global RNA-Based Therapeutics and Vaccines Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global RNA-Based Therapeutics and Vaccines Revenue and Market Share, Region Wise (2017-2022)
4.3 Global RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States RNA-Based Therapeutics and Vaccines Market Under COVID-19
4.5 Europe RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe RNA-Based Therapeutics and Vaccines Market Under COVID-19
4.6 China RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China RNA-Based Therapeutics and Vaccines Market Under COVID-19
4.7 Japan RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan RNA-Based Therapeutics and Vaccines Market Under COVID-19
4.8 India RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India RNA-Based Therapeutics and Vaccines Market Under COVID-19
4.9 Southeast Asia RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia RNA-Based Therapeutics and Vaccines Market Under COVID-19
4.10 Latin America RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America RNA-Based Therapeutics and Vaccines Market Under COVID-19
4.11 Middle East and Africa RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa RNA-Based Therapeutics and Vaccines Market Under COVID-19
5 GLOBAL RNA-BASED THERAPEUTICS AND VACCINES SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global RNA-Based Therapeutics and Vaccines Sales Volume and Market Share by Type (2017-2022)
5.2 Global RNA-Based Therapeutics and Vaccines Revenue and Market Share by Type (2017-2022)
5.3 Global RNA-Based Therapeutics and Vaccines Price by Type (2017-2022)
5.4 Global RNA-Based Therapeutics and Vaccines Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global RNA-Based Therapeutics and Vaccines Sales Volume, Revenue and Growth Rate of RNA-based Therapeutics (2017-2022)
5.4.2 Global RNA-Based Therapeutics and Vaccines Sales Volume, Revenue and Growth Rate of RNA-Based Vaccines (2017-2022)
6 GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET ANALYSIS BY APPLICATION
6.1 Global RNA-Based Therapeutics and Vaccines Consumption and Market Share by Application (2017-2022)
6.2 Global RNA-Based Therapeutics and Vaccines Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Oncology (2017-2022)
6.3.2 Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Immunology (2017-2022)
6.3.3 Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Ophthalmology (2017-2022)
6.3.4 Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Cardiovascular Diseases (2017-2022)
6.3.5 Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Infectious Diseases (2017-2022)
6.3.6 Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Genetic Diseases (2017-2022)
6.3.7 Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET FORECAST (2022-2027)
7.1 Global RNA-Based Therapeutics and Vaccines Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global RNA-Based Therapeutics and Vaccines Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global RNA-Based Therapeutics and Vaccines Price and Trend Forecast (2022-2027)
7.2 Global RNA-Based Therapeutics and Vaccines Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States RNA-Based Therapeutics and Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe RNA-Based Therapeutics and Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China RNA-Based Therapeutics and Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan RNA-Based Therapeutics and Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India RNA-Based Therapeutics and Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia RNA-Based Therapeutics and Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America RNA-Based Therapeutics and Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa RNA-Based Therapeutics and Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.3 Global RNA-Based Therapeutics and Vaccines Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global RNA-Based Therapeutics and Vaccines Revenue and Growth Rate of RNA-based Therapeutics (2022-2027)
7.3.2 Global RNA-Based Therapeutics and Vaccines Revenue and Growth Rate of RNA-Based Vaccines (2022-2027)
7.4 Global RNA-Based Therapeutics and Vaccines Consumption Forecast by Application (2022-2027)
7.4.1 Global RNA-Based Therapeutics and Vaccines Consumption Value and Growth Rate of Oncology(2022-2027)
7.4.2 Global RNA-Based Therapeutics and Vaccines Consumption Value and Growth Rate of Immunology(2022-2027)
7.4.3 Global RNA-Based Therapeutics and Vaccines Consumption Value and Growth Rate of Ophthalmology(2022-2027)
7.4.4 Global RNA-Based Therapeutics and Vaccines Consumption Value and Growth Rate of Cardiovascular Diseases(2022-2027)
7.4.5 Global RNA-Based Therapeutics and Vaccines Consumption Value and Growth Rate of Infectious Diseases(2022-2027)
7.4.6 Global RNA-Based Therapeutics and Vaccines Consumption Value and Growth Rate of Genetic Diseases(2022-2027)
7.4.7 Global RNA-Based Therapeutics and Vaccines Consumption Value and Growth Rate of Others(2022-2027)
7.5 RNA-Based Therapeutics and Vaccines Market Forecast Under COVID-19
8 RNA-BASED THERAPEUTICS AND VACCINES MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 RNA-Based Therapeutics and Vaccines Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of RNA-Based Therapeutics and Vaccines Analysis
8.6 Major Downstream Buyers of RNA-Based Therapeutics and Vaccines Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the RNA-Based Therapeutics and Vaccines Industry
9 PLAYERS PROFILES
9.1 Santaris Pharma A/S (A Roche Company)
9.1.1 Santaris Pharma A/S (A Roche Company) Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
9.1.3 Santaris Pharma A/S (A Roche Company) Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Regulus Therapeutics, Inc.
9.2.1 Regulus Therapeutics, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
9.2.3 Regulus Therapeutics, Inc. Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Dicerna Pharmaceuticals, Inc.
9.3.1 Dicerna Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
9.3.3 Dicerna Pharmaceuticals, Inc. Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Arbutus Biopharma Corp.
9.4.1 Arbutus Biopharma Corp. Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
9.4.3 Arbutus Biopharma Corp. Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 CureVac AG
9.5.1 CureVac AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
9.5.3 CureVac AG Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Alnylam Pharmaceuticals, Inc.
9.6.1 Alnylam Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
9.6.3 Alnylam Pharmaceuticals, Inc. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 BioNTech AG
9.7.1 BioNTech AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
9.7.3 BioNTech AG Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 miRagen Therapeutics
9.8.1 miRagen Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
9.8.3 miRagen Therapeutics Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Quark Pharmaceuticals, Inc.
9.9.1 Quark Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
9.9.3 Quark Pharmaceuticals, Inc. Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Moderna Therapeutics, Inc.
9.10.1 Moderna Therapeutics, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
9.10.3 Moderna Therapeutics, Inc. Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Marina Biotech, Inc.
9.11.1 Marina Biotech, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
9.11.3 Marina Biotech, Inc. Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Arrowhead Pharmaceuticals, Inc.
9.12.1 Arrowhead Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
9.12.3 Arrowhead Pharmaceuticals, Inc. Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure RNA-Based Therapeutics and Vaccines Product Picture
Table Global RNA-Based Therapeutics and Vaccines Market Sales Volume and CAGR (%) Comparison by Type
Table RNA-Based Therapeutics and Vaccines Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global RNA-Based Therapeutics and Vaccines Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global RNA-Based Therapeutics and Vaccines Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on RNA-Based Therapeutics and Vaccines Industry Development
Table Global RNA-Based Therapeutics and Vaccines Sales Volume by Player (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Sales Volume Share by Player (2017-2022)
Figure Global RNA-Based Therapeutics and Vaccines Sales Volume Share by Player in 2021
Table RNA-Based Therapeutics and Vaccines Revenue (Million USD) by Player (2017-2022)
Table RNA-Based Therapeutics and Vaccines Revenue Market Share by Player (2017-2022)
Table RNA-Based Therapeutics and Vaccines Price by Player (2017-2022)
Table RNA-Based Therapeutics and Vaccines Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global RNA-Based Therapeutics and Vaccines Sales Volume, Region Wise (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Sales Volume Market Share, Region Wise (2017-2022)
Figure Global RNA-Based Therapeutics and Vaccines Sales Volume Market Share, Region Wise (2017-2022)
Figure Global RNA-Based Therapeutics and Vaccines Sales Volume Market Share, Region Wise in 2021
Table Global RNA-Based Therapeutics and Vaccines Revenue (Million USD), Region Wise (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Revenue Market Share, Region Wise (2017-2022)
Figure Global RNA-Based Therapeutics and Vaccines Revenue Market Share, Region Wise (2017-2022)
Figure Global RNA-Based Therapeutics and Vaccines Revenue Market Share, Region Wise in 2021
Table Global RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Sales Volume by Type (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Sales Volume Market Share by Type (2017-2022)
Figure Global RNA-Based Therapeutics and Vaccines Sales Volume Market Share by Type in 2021
Table Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) by Type (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Type (2017-2022)
Figure Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Type in 2021
Table RNA-Based Therapeutics and Vaccines Price by Type (2017-2022)
Figure Global RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate of RNA-based Therapeutics (2017-2022)
Figure Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate of RNA-based Therapeutics (2017-2022)
Figure Global RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate of RNA-Based Vaccines (2017-2022)
Figure Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate of RNA-Based Vaccines (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Consumption by Application (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Consumption Market Share by Application (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Consumption Revenue (Million USD) by Application (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Consumption Revenue Market Share by Application (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Oncology (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Immunology (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Ophthalmology (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Cardiovascular Diseases (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Infectious Diseases (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Genetic Diseases (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Others (2017-2022)
Figure Global RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global RNA-Based Therapeutics and Vaccines Price and Trend Forecast (2022-2027)
Figure USA RNA-Based Therapeutics and Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe RNA-Based Therapeutics and Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China RNA-Based Therapeutics and Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan RNA-Based Therapeutics and Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India RNA-Based Therapeutics and Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia RNA-Based Therapeutics and Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America RNA-Based Therapeutics and Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa RNA-Based Therapeutics and Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global RNA-Based Therapeutics and Vaccines Market Sales Volume Forecast, by Type
Table Global RNA-Based Therapeutics and Vaccines Sales Volume Market Share Forecast, by Type
Table Global RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) Forecast, by Type
Table Global RNA-Based Therapeutics and Vaccines Revenue Market Share Forecast, by Type
Table Global RNA-Based Therapeutics and Vaccines Price Forecast, by Type
Figure Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate of RNA-based Therapeutics (2022-2027)
Figure Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate of RNA-based Therapeutics (2022-2027)
Figure Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate of RNA-Based Vaccines (2022-2027)
Figure Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate of RNA-Based Vaccines (2022-2027)
Table Global RNA-Based Therapeutics and Vaccines Market Consumption Forecast, by Application
Table Global RNA-Based Therapeutics and Vaccines Consumption Market Share Forecast, by Application
Table Global RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) Forecast, by Application
Table Global RNA-Based Therapeutics and Vaccines Revenue Market Share Forecast, by Application
Figure Global RNA-Based Therapeutics and Vaccines Consumption Value (Million USD) and Growth Rate of Oncology (2022-2027)
Figure Global RNA-Based Therapeutics and Vaccines Consumption Value (Million USD) and Growth Rate of Immunology (2022-2027)
Figure Global RNA-Based Therapeutics and Vaccines Consumption Value (Million USD) and Growth Rate of Ophthalmology (2022-2027)
Figure Global RNA-Based Therapeutics and Vaccines Consumption Value (Million USD) and Growth Rate of Cardiovascular Diseases (2022-2027)
Figure Global RNA-Based Therapeutics and Vaccines Consumption Value (Million USD) and Growth Rate of Infectious Diseases (2022-2027)
Figure Global RNA-Based Therapeutics and Vaccines Consumption Value (Million USD) and Growth Rate of Genetic Diseases (2022-2027)
Figure Global RNA-Based Therapeutics and Vaccines Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure RNA-Based Therapeutics and Vaccines Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Santaris Pharma A/S (A Roche Company) Profile
Table Santaris Pharma A/S (A Roche Company) RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Santaris Pharma A/S (A Roche Company) RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate
Figure Santaris Pharma A/S (A Roche Company) Revenue (Million USD) Market Share 2017-2022
Table Regulus Therapeutics, Inc. Profile
Table Regulus Therapeutics, Inc. RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Regulus Therapeutics, Inc. RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate
Figure Regulus Therapeutics, Inc. Revenue (Million USD) Market Share 2017-2022
Table Dicerna Pharmaceuticals, Inc. Profile
Table Dicerna Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Dicerna Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate
Figure Dicerna Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table Arbutus Biopharma Corp. Profile
Table Arbutus Biopharma Corp. RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Arbutus Biopharma Corp. RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate
Figure Arbutus Biopharma Corp. Revenue (Million USD) Market Share 2017-2022
Table CureVac AG Profile
Table CureVac AG RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure CureVac AG RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate
Figure CureVac AG Revenue (Million USD) Market Share 2017-2022
Table Alnylam Pharmaceuticals, Inc. Profile
Table Alnylam Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Alnylam Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate
Figure Alnylam Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table BioNTech AG Profile
Table BioNTech AG RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure BioNTech AG RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate
Figure BioNTech AG Revenue (Million USD) Market Share 2017-2022
Table miRagen Therapeutics Profile
Table miRagen Therapeutics RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure miRagen Therapeutics RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate
Figure miRagen Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Quark Pharmaceuticals, Inc. Profile
Table Quark Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Quark Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate
Figure Quark Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table Moderna Therapeutics, Inc. Profile
Table Moderna Therapeutics, Inc. RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Moderna Therapeutics, Inc. RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate
Figure Moderna Therapeutics, Inc. Revenue (Million USD) Market Share 2017-2022
Table Marina Biotech, Inc. Profile
Table Marina Biotech, Inc. RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Marina Biotech, Inc. RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate
Figure Marina Biotech, Inc. Revenue (Million USD) Market Share 2017-2022
Table Arrowhead Pharmaceuticals, Inc. Profile
Table Arrowhead Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Arrowhead Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate
Figure Arrowhead Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Figure RNA-Based Therapeutics and Vaccines Product Picture
Table Global RNA-Based Therapeutics and Vaccines Market Sales Volume and CAGR (%) Comparison by Type
Table RNA-Based Therapeutics and Vaccines Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global RNA-Based Therapeutics and Vaccines Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global RNA-Based Therapeutics and Vaccines Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on RNA-Based Therapeutics and Vaccines Industry Development
Table Global RNA-Based Therapeutics and Vaccines Sales Volume by Player (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Sales Volume Share by Player (2017-2022)
Figure Global RNA-Based Therapeutics and Vaccines Sales Volume Share by Player in 2021
Table RNA-Based Therapeutics and Vaccines Revenue (Million USD) by Player (2017-2022)
Table RNA-Based Therapeutics and Vaccines Revenue Market Share by Player (2017-2022)
Table RNA-Based Therapeutics and Vaccines Price by Player (2017-2022)
Table RNA-Based Therapeutics and Vaccines Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global RNA-Based Therapeutics and Vaccines Sales Volume, Region Wise (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Sales Volume Market Share, Region Wise (2017-2022)
Figure Global RNA-Based Therapeutics and Vaccines Sales Volume Market Share, Region Wise (2017-2022)
Figure Global RNA-Based Therapeutics and Vaccines Sales Volume Market Share, Region Wise in 2021
Table Global RNA-Based Therapeutics and Vaccines Revenue (Million USD), Region Wise (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Revenue Market Share, Region Wise (2017-2022)
Figure Global RNA-Based Therapeutics and Vaccines Revenue Market Share, Region Wise (2017-2022)
Figure Global RNA-Based Therapeutics and Vaccines Revenue Market Share, Region Wise in 2021
Table Global RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Sales Volume by Type (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Sales Volume Market Share by Type (2017-2022)
Figure Global RNA-Based Therapeutics and Vaccines Sales Volume Market Share by Type in 2021
Table Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) by Type (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Type (2017-2022)
Figure Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Type in 2021
Table RNA-Based Therapeutics and Vaccines Price by Type (2017-2022)
Figure Global RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate of RNA-based Therapeutics (2017-2022)
Figure Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate of RNA-based Therapeutics (2017-2022)
Figure Global RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate of RNA-Based Vaccines (2017-2022)
Figure Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate of RNA-Based Vaccines (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Consumption by Application (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Consumption Market Share by Application (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Consumption Revenue (Million USD) by Application (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Consumption Revenue Market Share by Application (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Oncology (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Immunology (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Ophthalmology (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Cardiovascular Diseases (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Infectious Diseases (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Genetic Diseases (2017-2022)
Table Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate of Others (2017-2022)
Figure Global RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global RNA-Based Therapeutics and Vaccines Price and Trend Forecast (2022-2027)
Figure USA RNA-Based Therapeutics and Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe RNA-Based Therapeutics and Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China RNA-Based Therapeutics and Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan RNA-Based Therapeutics and Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India RNA-Based Therapeutics and Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia RNA-Based Therapeutics and Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America RNA-Based Therapeutics and Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa RNA-Based Therapeutics and Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global RNA-Based Therapeutics and Vaccines Market Sales Volume Forecast, by Type
Table Global RNA-Based Therapeutics and Vaccines Sales Volume Market Share Forecast, by Type
Table Global RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) Forecast, by Type
Table Global RNA-Based Therapeutics and Vaccines Revenue Market Share Forecast, by Type
Table Global RNA-Based Therapeutics and Vaccines Price Forecast, by Type
Figure Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate of RNA-based Therapeutics (2022-2027)
Figure Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate of RNA-based Therapeutics (2022-2027)
Figure Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate of RNA-Based Vaccines (2022-2027)
Figure Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate of RNA-Based Vaccines (2022-2027)
Table Global RNA-Based Therapeutics and Vaccines Market Consumption Forecast, by Application
Table Global RNA-Based Therapeutics and Vaccines Consumption Market Share Forecast, by Application
Table Global RNA-Based Therapeutics and Vaccines Market Revenue (Million USD) Forecast, by Application
Table Global RNA-Based Therapeutics and Vaccines Revenue Market Share Forecast, by Application
Figure Global RNA-Based Therapeutics and Vaccines Consumption Value (Million USD) and Growth Rate of Oncology (2022-2027)
Figure Global RNA-Based Therapeutics and Vaccines Consumption Value (Million USD) and Growth Rate of Immunology (2022-2027)
Figure Global RNA-Based Therapeutics and Vaccines Consumption Value (Million USD) and Growth Rate of Ophthalmology (2022-2027)
Figure Global RNA-Based Therapeutics and Vaccines Consumption Value (Million USD) and Growth Rate of Cardiovascular Diseases (2022-2027)
Figure Global RNA-Based Therapeutics and Vaccines Consumption Value (Million USD) and Growth Rate of Infectious Diseases (2022-2027)
Figure Global RNA-Based Therapeutics and Vaccines Consumption Value (Million USD) and Growth Rate of Genetic Diseases (2022-2027)
Figure Global RNA-Based Therapeutics and Vaccines Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure RNA-Based Therapeutics and Vaccines Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Santaris Pharma A/S (A Roche Company) Profile
Table Santaris Pharma A/S (A Roche Company) RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Santaris Pharma A/S (A Roche Company) RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate
Figure Santaris Pharma A/S (A Roche Company) Revenue (Million USD) Market Share 2017-2022
Table Regulus Therapeutics, Inc. Profile
Table Regulus Therapeutics, Inc. RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Regulus Therapeutics, Inc. RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate
Figure Regulus Therapeutics, Inc. Revenue (Million USD) Market Share 2017-2022
Table Dicerna Pharmaceuticals, Inc. Profile
Table Dicerna Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Dicerna Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate
Figure Dicerna Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table Arbutus Biopharma Corp. Profile
Table Arbutus Biopharma Corp. RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Arbutus Biopharma Corp. RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate
Figure Arbutus Biopharma Corp. Revenue (Million USD) Market Share 2017-2022
Table CureVac AG Profile
Table CureVac AG RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure CureVac AG RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate
Figure CureVac AG Revenue (Million USD) Market Share 2017-2022
Table Alnylam Pharmaceuticals, Inc. Profile
Table Alnylam Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Alnylam Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate
Figure Alnylam Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table BioNTech AG Profile
Table BioNTech AG RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure BioNTech AG RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate
Figure BioNTech AG Revenue (Million USD) Market Share 2017-2022
Table miRagen Therapeutics Profile
Table miRagen Therapeutics RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure miRagen Therapeutics RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate
Figure miRagen Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Quark Pharmaceuticals, Inc. Profile
Table Quark Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Quark Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate
Figure Quark Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table Moderna Therapeutics, Inc. Profile
Table Moderna Therapeutics, Inc. RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Moderna Therapeutics, Inc. RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate
Figure Moderna Therapeutics, Inc. Revenue (Million USD) Market Share 2017-2022
Table Marina Biotech, Inc. Profile
Table Marina Biotech, Inc. RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Marina Biotech, Inc. RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate
Figure Marina Biotech, Inc. Revenue (Million USD) Market Share 2017-2022
Table Arrowhead Pharmaceuticals, Inc. Profile
Table Arrowhead Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Arrowhead Pharmaceuticals, Inc. RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate
Figure Arrowhead Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
